Between-trial heterogeneity in ARDS research

ARDS plus pulmonary hypertension raises odds for mortality, longer hospital stay

Clinical relevance of timing of assessment of ICU mortality in patients with moderate-to-severe Acute Respiratory Distress Syndrome

IJMS, Free Full-Text

Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling - ScienceDirect

Frontiers Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2

Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes - The Lancet

Frontiers Pharmacologic therapies of ARDS: From natural herb to nanomedicine

JCM, Free Full-Text

Advancing precision medicine for acute respiratory distress syndrome - The Lancet Respiratory Medicine

Mitigating Coronavirus-Induced Acute Respiratory Distress Syndrome by Radiotherapy - ScienceDirect

Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management - The Lancet